Cigna Corporation and Subsidiaries
Employee benefits company.
Based in DC
AI Overview
With $1.6M in lobbying spend across 18 quarterly filings, Cigna Corporation and Subsidiaries is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $270K |
| 2022 | $360K |
| 2023 | $360K |
| 2024 | $360K |
| 2025 | $270K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Defense
Proposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program.
Issues impacting insurance coverage, prescription drugs and the federal COVID response; Issues related to importation of prescription drugs.
Issues impacting insurance coverage, prescription drugs and the federal COVID response.
Proposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program; S. Con Res 14 and the impact on the expansion of Medicare benefits.
Proposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program; Issues related to H.R. 5376 - The Build Back Better Act's impact on Medicare Advantage and prescription drug pricing.
Proposals impacting Medicare Advantage and Medicare Part D.
Issues impacting insurance coverage, prescription drugs and the federal COVID response; Issues impacting mental health care; Issues impacting employer sponsored insurance.
Proposals impacting Medicare Advantage and Medicare Part D; Issues related to the Advance Notice of Methodological Changes for Calendar Year 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies.
Showing 8 of 20 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.